4//SEC Filing
Niederhuber John 4
Accession 0001209191-22-033928
CIK 0001671584other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 3:06 PM ET
Size
12.5 KB
Accession
0001209191-22-033928
Insider Transaction Report
Form 4
Niederhuber John
Director
Transactions
- Exercise/Conversion
Common Stock
2022-06-01+298→ 1,814 total - Purchase
Common Stock
2019-06-14$0.91/sh+714$650→ 1,516 total - Exercise/Conversion
Restricted Stock Unit
2022-06-01−298→ 595 total→ Common Stock (298 underlying)
Holdings
- 802
Common Stock
Footnotes (4)
- [F1]Shares received in a pro rata distribution by Emergent BioSolutions Inc. ("Emergent") as a result of the spin-off of the Issuer from Emergent, effective August 1, 2016, and adjusted to reflect a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020.
- [F2]Reflects a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020.
- [F3]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F4]On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001501240
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 3:06 PM ET
- Size
- 12.5 KB